BGS · B&G Foods
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $3.90
Note written ·
Price against the kill line
5.9% clear of its kill line on the 17 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 17 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $3.90, set on 16 November 2026. The shares are up 6.7% since the close; the S&P 500 is down 4.5% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $3.90, over the 200-day moving average and the 11 November 2026 post-report close of $3.67, which would show the shares leading; or a signed Green Giant Canada sale with proceeds directed to debt reduction.
Research onlyNot in the portfolio.
Catalyst
The business · as of
B&G Foods sells shelf-stable and frozen grocery brands (Crisco, Ortega, Cream of Wheat, College Inn broth, Green Giant in Canada) to supermarkets, mass retailers and food-service distributors, earning a margin on branded volume. Net sales were $459.8 million in the quarter to 3 October 2026.
What is changing, and what follows · as of
- What is changing now
- On 10 November 2026 the company reported third-quarter net sales up 4.7% to $459.8 million, base business volume up 6.1%, and raised its 2026 adjusted EBITDA outlook to $280–290 million.
- What follows for the company
- Interest on the 11% notes due 2031 lifted quarterly net interest expense to $44.8 million; free cash flow of $99 million over four quarters goes to debt, and the leverage goal moved to mid-2027.
- What follows for its customers, suppliers and competitors
- Walmart (WMT), its largest retail customer, gains a supplier with rising volume; College Inn broth competes with Campbell's (CPB), and shelf-stable brands with Conagra (CAG) and General Mills (GIS).
What the price assumes · as of
At the 13 November 2026 close (filed inputs to 10 November 2026) the shares trade at 1.3 times sales and 34.2 times EBIT, with P/E not meaningful and a 35.0% free-cash-flow yield on a $284 million market value; that holds only if the $99 million of four-quarter free cash flow keeps paying down $2,040 million of debt while the 3.1% operating margin of the latest quarter widens.
Key figures from the filings · Consumer Staples
Quarter to 3 October 2026, filed 10 November 2026; valuation at the 17 November 2026 close
- Revenue, latest quarter ($M)
- 460
- Revenue, change on a year (%)
- +4.7
- Gross margin (%)
- 23.7
- Operating margin (%)
- 3.1
- Free cash flow, four quarters ($M)
- 99.5
- Net cash, cash less debt ($M)
- −1,978
- Enterprise value to sales (×)
- 1.3
- Enterprise value to operating income (×)
- 34.4
All filed numbers
What B&G Foods reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 460 | +4.7 | 23.7 | 3.1 |
| first filed | 383 | −9.7 | 20.8 | 9.0 |
| first filed | 409 | −3.9 | 19.5 | −2.7 |
| first filed | 540 | −2.2 | 22.7 | 5.2 |
| first filed | 439 | −4.7 | 22.5 | 2.5 |
| first filed | 424 | −4.5 | 20.5 | 5.2 |
| Pre-tax income ($M) | −29.0 |
| Net income ($M) four quarters: −84.2 | −32.5 |
| Diluted shares, change on a year (%) against the quarter to 27 September 2025 | +1.5 |
| Operating cash flow ($M) | 125 |
| Capital spending ($M) | 25.5 |
| Free cash flow ($M) | 99.5 |
| Cash and short-term investments ($M) | 61.7 |
| Debt ($M) long-term debt | 2,040 |
| Net cash, cash less debt ($M) | −1,978 |
| Deferred revenue ($M) | Not reported |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 166 |
| Inventory ($M) | 425 |
| Shareholders' equity ($M) | 355 |
| Market value ($M) | 298 |
| Enterprise value, market value plus net debt ($M) | 2,276 |
| Enterprise value to sales (×) | 1.3 |
| Enterprise value to operating income (×) | 34.4 |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 0.8 |
| Free-cash-flow yield (%) | 33.4 |
Short interest (FINRA, settled 30 October 2026, published 10 November 2026): 17.5% of shares outstanding sold short, 7.0 days of average trading to cover, +3.7% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 days | Not available yet | Not available yet |
| 12 months | Not available yet | Not available yet |
Linked companies · as of
- Customers:
- WMT
- Competitors:
- CPB, CAG, GIS
The thesis
B&G Foods' shares are more likely to lag the S&P 500 over the next three months. The 10 November 2026 third-quarter beat is real, but the market repriced it in one session. Debt of about $2,040 million and 11% notes leave a thin equity cushion. No company report is due before the fiscal 2026 fourth-quarter results, expected in late February 2027. The rating is Low because the next test of the deleveraging plan comes at the very end of the three-month window, while the debt load stays where it is until then.
The quarter improved. Net sales rose 4.7% to $459.8 million and base business sales grew 5.0% on a 6.1% volume gain, according to the company's 10 November 2026 8-K. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) rose 16.2% to $81.8 million. Management raised the 2026 sales outlook to $1.760–1.800 billion and adjusted EBITDA to $280–290 million. The shares closed at $2.66 on 10 November 2026 and $3.67 on 11 November 2026.
The balance sheet still governs. Earnings Whispers reported on 11 November 2026 that covenant leverage sat near 6.4 times at the seasonal peak. The target of roughly 6 times by mid-2026 has moved to below 6 times by mid-2027. The same report puts full-year interest expense guidance at $160–165 million, which absorbs more than half of the guided adjusted EBITDA.
Bullish and bearish views on B&G Foods, Inc.
The bull case on B&G Foods, Inc. (BGS), in brief: volume turned positive in the third quarter. The bear case: debt dwarfs the equity.
Bull case
- Volume turned positive in the third quarter. Base business net sales rose 5.0% to $404.6 million in the quarter to 3 October 2026, with volume adding $23.6 million (6.1%), per the 10 November 2026 8-K.
- Margins widened as volume returned. Adjusted gross margin was 24.2% against 22.5% a year earlier, and the adjusted EBITDA margin reached 17.8% against 16.0% (8-K, 10 November 2026).
- Outlook raised for the second time in 2026. The 2026 net sales range rose to $1.760–1.800 billion from $1.735–1.775 billion, and adjusted EBITDA guidance rose to $280–290 million (company release, 10 November 2026).
- Cash generation is large against the equity. Free cash flow was $99 million over the four quarters to 3 October 2026, against a market value of $284 million at the 13 November 2026 close (10-Q filed 10 November 2026).
- A director bought near the lows. Director DeAnn Brunts bought 5,616 shares in the open market at $3.21 on 14 September 2026 (SEC Form 4, filed 15 September 2026).
Bear case
- Debt dwarfs the equity. Debt stood at $2,039.9 million against $61.7 million of cash on 3 October 2026, and the enterprise value of $2,262 million at the 13 November 2026 close is roughly eight times the market value (10-Q, filed 10 November 2026).
- Refinancing raised the cost of debt. The company issued 11.00% senior notes due 2031 on 10 June 2026 to retire its 5.25% notes due 2027. Third-quarter net interest expense was $44.8 million (8-K, 10 November 2026).
- Deleveraging target pushed back a year. Earnings Whispers reported on 11 November 2026 that the leverage goal moved from about 6 times by mid-2026 to below 6 times by mid-2027.
- Brand sales come with write-downs. A $40.7 million impairment on the B&M and Joan of Arc trademarks preceded their sale on 13 October 2026, and the quarter's net loss was $32.5 million (8-K, 10 November 2026).
- Green Giant Canada remains unsold. The planned sale of the Canadian business was canceled, removing expected proceeds, per Earnings Whispers on 11 November 2026; the company's 2026 guidance excludes any divestiture impact.
Price setup
The shares closed at $3.50 on 13 November 2026. That is above the 50-day moving average of $2.68 and below the 200-day moving average of $3.81, both on adjusted daily closes as of 13 November 2026. The 3-month change is +4.7%.
The 52-week closing low was $2.04 on 26 October 2026, two weeks before the report. The 52-week intraday high was $6.38 on 4 March 2026, and the last close sits 45.1% below it. After the report the shares closed at $3.67 on 11 November 2026, then $3.35 on 12 November 2026, giving back part of the gain.
The 200-day average is the level the case turns on. A sustained move above it would mean the market is pricing the volume recovery as durable before the deleveraging is proven. For stocks after a one-day jump of this size, tests on ten years of US prices show no reliable effect found so far on the next three months. Across liquid US stocks, the standard deviation of 63-session returns was 27% in 2026, a description of how widely three-month outcomes spread.
Catalysts ahead
- ~25 February 2027 (est.): Fiscal 2026 fourth-quarter and full-year results, with the 2027 outlook. Shows whether base business volume growth held, whether adjusted EBITDA landed in the $280–290 million range, and how far leverage fell toward the below-6-times goal for mid-2027.
What would change the view
A daily close above $3.90, over the 200-day moving average and the 11 November 2026 post-report close of $3.67, which would show the shares leading; or a signed Green Giant Canada sale with proceeds directed to debt reduction.
What it trades with
B&G Foods trades as a leveraged equity on a packaged-food business. The shares respond to its own credit story (leverage ratios, note yields, asset sales) more than to sector moves. Its listed peers in shelf-stable food, Campbell's (CPB), Conagra Brands (CAG) and General Mills (GIS), carry far less debt against their earnings, so their price moves track sector demand more closely. A widening in high-yield credit spreads would pressure the shares through the cost of the 11% notes and any future refinancing. Moves in the consumer-brands group the stock is grouped with have little bearing on a grocery staples company carrying this much debt.
Caveats
- Third-quarter 2026 net sales include $26.3 million from a co-manufacturing agreement for the divested Green Giant U.S. frozen business, which is not branded sales. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- The quarterly dividend is $0.095 a share, declared 29 October 2026; the dividend was halved earlier in 2026. B&G Foods dividend declaration, 29 October 2026 · as of
The evidence, claim by claim (8)
- Third-quarter net sales rose 4.7% to $459.8 million; base business net sales rose 5.0% to $404.6 million on a 6.1% volume increase. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- Third-quarter adjusted EBITDA rose 16.2% to $81.8 million, or 17.8% of net sales against 16.0% a year earlier. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- 2026 guidance raised to net sales of $1.760–1.800 billion and adjusted EBITDA of $280–290 million; adjusted diluted EPS reaffirmed at $0.575–0.675. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- Third-quarter net loss was $32.5 million, including a $40.7 million non-cash impairment on the B&M and Joan of Arc trademarks, sold on 13 October 2026. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- Debt was $2,039.9 million against cash of $61.7 million at the end of the quarter. Form 10-Q for the quarter ended 3 October 2026 · as of
- 11.00% senior notes due 2031 were issued on 10 June 2026 and the 5.25% senior notes due 2027 were redeemed in the third quarter; net interest expense was $44.8 million in the quarter. B&G Foods 8-K, Exhibit 99.1, 10 November 2026 · as of
- Covenant leverage sat near 6.4 times at the seasonal peak; the target moved to below 6 times by mid-2027 and interest expense guidance rose to $160–165 million. Earnings Whispers, 11 November 2026 · as of
- Director DeAnn Brunts bought 5,616 shares in the open market at $3.21 on 14 September 2026. SEC Form 4, filed 15 September 2026 · as of
Sources
Related · shared themes
CPRI
Capri Holdings
Capri Holdings' Michael Kors turnaround gives the shares a modest edge over the S&P 500 after the 30 October 2026 beat-and-raise, despite a…
CROX
Crocs
Crocs, Inc. is more likely to lead the S&P 500 over three months: a third-quarter beat and a third guidance raise lifted full-year adjusted…
CRSR
Corsair Gaming
Corsair Gaming's recovery case holds after it beat third-quarter guidance and raised its 2026 outlook on 5 November 2026; the…
EL
Estee Lauder Companies
Estée Lauder's turnaround now shows in sales as well as margins, with first-quarter organic sales up 6% and the fiscal 2027 outlook raised…